Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced or Metastatic Solid Tumor Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT05788107
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of HLX51 in Patients With Solid Tumor or Lymphoma

Who this might be right for
Solid Tumor, Adult Lymphoma
Shanghai Henlius Biotech 30
Testing effectiveness (Phase 2)Looking for participantsNCT07819136
What this trial is testing

REC-7735 in Participants With Solid Tumors

Who this might be right for
Solid Tumors
Recursion Pharmaceuticals Inc. 90
Early research (Phase 1)Study completedNCT02867397
What this trial is testing

Study of Teysuno (S-1) Combined With Epirubicin and Oxaliplatin in Patients With Advanced Solid Tumors

Who this might be right for
Patients With Advanced or Metastatic Solid Tumors
Disphar International B.V. 25
Testing effectiveness (Phase 2)WithdrawnNCT03427320
What this trial is testing

Imaging of Advanced Tumours Using [131]I-IAZA

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid Tumors
University of Alberta
Early research (Phase 1)UnknownNCT05263986
What this trial is testing

The Clinical Trial to Evaluate the Pharmacokinetics and Safety of MRTX849 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumor
Zai Lab (Shanghai) Co., Ltd. 22
Early research (Phase 1)Looking for participantsNCT07807241
What this trial is testing

MX006 in Patients With Advanced and/or Metastatic Tumors Known to Express B7-H3

Who this might be right for
Advanced and/or Metastatic Solid Tumors Known to Express B7-H3
Myricx Pharma Limited 120
Very early researchUnknownNCT06026605
What this trial is testing

A Dose Escalation and Dose Expansion Trial of WTX212A in the Treatment of Patients with Advanced Malignant Tumors

Who this might be right for
Unresectable or Metastatic Advanced Solid Tumors
Zhejiang University 44
Large-scale testing (Phase 3)Active Not RecruitingNCT06635824
What this trial is testing

Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)

Who this might be right for
PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC
Genmab 191
Early research (Phase 1)Study completedNCT03287427
What this trial is testing

MYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies Trial

Who this might be right for
Colorectal CancerAdenoid Cystic Carcinoma
Peter MacCallum Cancer Centre, Australia 27
Early research (Phase 1)Study completedNCT00099190
What this trial is testing

ARQ 501 in Combination With Docetaxel in Patients With Cancer

Who this might be right for
Carcinoma
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 50
Early research (Phase 1)Study completedNCT01603979
What this trial is testing

Dose Escalation Study of AV-203, an ERBB3 Inhibitory Antibody, in Subjects With Advanced Solid Tumors

Who this might be right for
Solid Tumors
AVEO Pharmaceuticals, Inc. 24
Early research (Phase 1)Looking for participantsNCT04617522
What this trial is testing

Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment

Who this might be right for
Advanced or Metastatic Solid TumorLiver Failure
Gilead Sciences 30
Early research (Phase 1)Not Yet RecruitingNCT07686445
What this trial is testing

AN4035 in Advanced Cancers With RAS Mutations and High CEACAM5 Expression

Who this might be right for
Solid Tumor (Phase I)RAS MutationCEACAM5
Adlai Nortye Biopharma Co., Ltd. 228
Testing effectiveness (Phase 2)Active Not RecruitingNCT05379946
What this trial is testing

Study to Evaluate D-1553 in Combination With IN10018 in Subjects With Solid Tumors

Who this might be right for
Solid Tumor
InventisBio Co., Ltd 92
Testing effectiveness (Phase 2)UnknownNCT04326829
What this trial is testing

QL1604 Monotherapy for dMMR or MSI-H Advanced Solid Tumors

Who this might be right for
Advanced Malignant Tumor
Qilu Pharmaceutical Co., Ltd. 86
Early research (Phase 1)Ended earlyNCT02419495
What this trial is testing

Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+26 more
M.D. Anderson Cancer Center 221
Early research (Phase 1)Looking for participantsNCT06475131
What this trial is testing

BL-B16D1 in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 21
Early research (Phase 1)Study completedNCT01222637
What this trial is testing

CetuGEX™: Phase 1 Study in Cancer Patients

Who this might be right for
Solid Tumors
Glycotope GmbH 41
Early research (Phase 1)Looking for participantsNCT06960395
What this trial is testing

Safety and Preliminary Efficacy of VIR-5525 and VIR-5525 + Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor MalignanciesEGFR Positive Solid TumorsEGFR
Vir Biotechnology, Inc. 450
Early research (Phase 1)Ended earlyNCT05605522
What this trial is testing

[225Ac]-FPI-2059 in Adult Participants With Solid Tumours

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Squamous Cell Carcinoma of Head and NeckColorectal Cancer+4 more
3B Pharmaceuticals GmbH 19
Next Page